Kira Macdougall, MD
Medical Oncology · Santa Fe, NMNPI 1770072001
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,449 of the $3,328 with a category attached, or 73.6%. It is spread thinly across 33 manufacturers, the largest accounting for just 19.0%. 2025 is the largest year on record at $1,214, 4.6 times the $262 reported in 2021.
Across 96 payments — averaging $34.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$631
- Seagen Inc.$299
- Exelixis Inc.$177
- Secura Bio, Inc.$170
- Takeda Pharmaceuticals U.S.A., Inc.$164
- AVEO Pharmaceuticals, Inc.$161
- plus $2K from 27 others
What the payments were for
- Food & beverage$2,44974%
- Education$87926%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 19 | $631 |
| Seagen Inc. | 3 | $299 |
| Exelixis Inc. | 8 | $177 |
| Secura Bio, Inc. | 1 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $164 |
| AVEO Pharmaceuticals, Inc. | 2 | $161 |
| Gilead(2 entities) | 6 | $159 |
| Astellas Pharma US Inc | 2 | $157 |
| Incyte Corporation | 4 | $149 |
| Johnson & Johnson | 8 | $145 |
| Mallinckrodt Hospital Products Inc. | 1 | $144 |
| Novocure Inc. | 1 | $131 |
| ADC Therapeutics America, Inc. | 1 | $116 |
| Novartis | 5 | $111 |
| Sanofi | 3 | $87 |
| Bayer | 3 | $62 |
| Array Biopharma Inc | 3 | $57 |
| Blueprint Medicines Corporation | 2 | $56 |
| Beigene USA, Inc. | 2 | $39 |
| Sobi, Inc | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Iovance Biotherapeutics, Inc. | 1 | $30 |
| Daiichi Sankyo Inc. | 2 | $30 |
| AbbVie | 1 | $28 |
| Merck | 1 | $23 |
| Pharmaessentia USA Corporation | 1 | $22 |
| Legend Biotech USA Inc. | 1 | $21 |
| Genmab U.S., Inc. | 1 | $20 |
| Eisai Inc. | 1 | $18 |
| EMD Serono, Inc. | 1 | $17 |
| Karyopharm Therapeutics Inc. | 1 | $16 |
| GSK | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Copiktra$170
- UVADEX$144
- Optune Gio$131
How this compares
Too few medical oncology providers in New Mexicoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abiraterone Acetate | 11 | $30,793 |
| Anastrozole | 20 | $170 |
| Ondansetron OdtOndansetron | 15 | $156 |
| Prednisone | 18 | $54 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Santa Fe
- Annette FontaineAlbuquerque$208K
- Katherine SanchezAlbuquerque$26K
- Benjamin DownieClovis$14K
- Constance WashLas Cruces$9K
- Atul KumarAlbuquerque$9K
- Sofia Palacio CardenasAlbuquerque$5K
- Malcolm PurdyAlbuquerque$3K
- Amyn AlidinaAlbuquerque$2K
- Ronald KubicaAlbuquerque$1K
- Joseph EkofoAlbuquerque$195
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.